Výsledky vyhledávání

Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group

Autor: G, Steiner, N C, Pauly

Publikováno v: Journal of cardiovascular pharmacology. 23

After a single-blind, 4-week placebo run-in period, 161 patients were randomized to trandolapril 2 mg once daily (n = 54), nifedipine slow-release (SR) 20 mg twice daily (n = 55), or a combination of both drugs (n = 52) for 16 weeks. Morning predosin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8e21e50279e239f64852069f58c86ecd
https://pubmed.ncbi.nlm.nih.gov/7527108

Zobrazit plný text záznamu

Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group

Autor: N C, Pauly, M E, Safar

Publikováno v: Journal of cardiovascular pharmacology. 23

This multicenter international trial recruited 180 patients from 27 investigators. After a 4-week, single-blind placebo run-in, patients were randomized double-blind to 16 weeks of trandolapril 4 mg o.d. or captopril 50 mg b.i.d. If blood pressure wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22d0d48cd719c7fd056c1939f8b01e9f
https://pubmed.ncbi.nlm.nih.gov/7527106

Zobrazit plný text záznamu

Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group

Autor: B H, Meyer, N C, Pauly

Publikováno v: Journal of cardiovascular pharmacology. 23

This multicenter international trial recruited 205 patients from 16 investigators. After a 4-week, single-blind placebo run-in, patients were randomized to receive 16 weeks of trandolapril 2 mg/day (68 patients), hydrochlorothiazide (HCTZ) 25 mg/day

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4c3011e216b8de35d04d1be08427df7d
https://pubmed.ncbi.nlm.nih.gov/7527107

Zobrazit plný text záznamu

Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. Investigator Study Group

Autor: J H, De Bruijn, B A, Orofiamma, N C, Pauly

Publikováno v: Journal of cardiovascular pharmacology. 23

This double-blind, placebo-controlled, dose-ranging study recruited 170 patients with mild-to-moderate hypertension from nine centers. After a 4-week, single-blind, placebo run-in phase, patients were randomized in a double-blind fashion to four para

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d6e46ab86ae2179babd39b107ab2e2d7
https://pubmed.ncbi.nlm.nih.gov/7527104

Zobrazit plný text záznamu

Converting enzyme inhibition: dissociation between antihypertensive and arterial effects

Autor: R G, Asmar, A, Benetos, B M, Darne, N C, Pauly, M E, Safar

Publikováno v: Journal of human hypertension. 6(5)

In this study the dose-response curves reflecting the arterial and the antihypertensive effects of converting enzyme inhibition were analysed. The BP measurement (using a random zero sphygmomanometer) and its decrease following converting enzyme inhi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::555242e04a44fd907f8d10945a40b00e
https://pubmed.ncbi.nlm.nih.gov/1464895

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání